S. Ashley

发表

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.

T. Powles, M. Dowsett, J. Davey, 1989, British Journal of Cancer.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.

T. Powles, Jenny C. Chang, T. Hickish, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Fine Needle Aspiration Cytodiagnosis As A Pre‐Requisite For Primary Medical Treatment of Breast Cancer

T. Powles, R. Coombes, S. Clarke, 1991, Cytopathology : official journal of the British Society for Clinical Cytology.

Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.

T. Powles, M. Dowsett, Jenny C. Chang, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.

M. Lodge, P. Goldstraw, S. Ashley, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Feasibility of the use of the Active Breathing Co ordinator (ABC) in patients receiving radical radiotherapy for non-small cell lung cancer (NSCLC).

Philip M Evans, Anthony Kavanagh, Michael Brada, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Temozolomide as Second-line Chemotherapy for Relapsed Gliomas

S. Ashley, S. Short, M. Brada, 2002, Journal of Neuro-Oncology.

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.

M. Dowsett, S. Ebbs, J. Salter, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma (PCL).

S. Ashley, M. Brada, D. Traish, 1998, International journal of radiation oncology, biology, physics.

Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a three-point thermoplastic shell.

V. Khoo, K. Pennert, S. Ashley, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

The long‐term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas

D Uttley, M Brada, S. Ashley, 1993, Clinical endocrinology.

Cerebrovascular mortality in patients with pituitary adenoma

S. Ashley, S. Ashley, M. Brada, 2002, Clinical endocrinology.

Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.

S. Ashley, M. Brada, B. Rajan, 1994, European journal of cancer.

Variation in endometrial thickening in women with amenorrhea on tamoxifen

T. Powles, M. Dowsett, S. Ashley, 1998, Breast Cancer Research and Treatment.

The Royal Marsden Hospital pilot tamoxifen chemoprevention trial

T. Powles, J. Davey, M. Baum, 2004, Breast Cancer Research and Treatment.

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme.

T. Powles, J. Davey, S. Ashley, 1990, European journal of cancer.

Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.

M. Nicolson, S. Ashley, T. Powles, 1992, British Journal of Cancer.

Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial

T. Powles, M. Dowsett, I. Smith, 2017, Cancer Prevention Research.

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

T. Bourne, W. Collins, S. Campbell, 1994, The Lancet.

Selective avoidance of lymphatic radiotherapy in the conservative management of women with early breast cancer.

J. Yarnold, S. Ebbs, L. Gothard, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Improving outcomes in non-small cell lung cancer; population analysis of radical radiotherapy.

S. Ashley, M. Brada, S. Mitchell, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma

T. Powles, M. Dowsett, A. Harris, 1999, Cancer.

The effect of Premium View post-processing software on digital mammographic reporting.

S. Ashley, I. Castellano, S. Allen, 2010, The British journal of radiology.

Chemoprevention of breast cancer

T. Powles, M. Dowsett, J. Davey, 1989, Breast Cancer Research and Treatment.

An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery.

T. Powles, S. Ashley, C. Harmer, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Effects of growth factors on proliferation of basal and luminal cells in human breast epithelial explants in serum-free culture

B. Gusterson, M. O'hare, S. Ashley, 1992, In Vitro Cellular & Developmental Biology - Animal.

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.

I. Judson, J. Hardy, S. Ashley, 1991, British Journal of Cancer.

c-erbB-2 expression in benign and malignant breast disease.

B. Gusterson, W. Gullick, S. Ashley, 1988, British Journal of Cancer.

Immunohistochemical localization of c-erbB-2 in human breast carcinomas.

B. Gusterson, W. Gullick, S. Ashley, 1987, Molecular and cellular probes.

Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.

T. Powles, M. Dowsett, S. Ashley, 1994, British Journal of Cancer.

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.

T. Powles, S. Ashley, J. Chang, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer

M. Dowsett, S. Ebbs, J. Salter, 2006, Clinical Cancer Research.

MENSTRUAL EFFECT ON SURGICAL CURE OF BREAST CANCER

T. Powles, R. Gelber, A. Goldhirsch, 1989, The Lancet.

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome.

T. Powles, S. Ashley, M. O'Brien, 1993, European journal of cancer.

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.

M. Dowsett, S. Ebbs, J. Blohmer, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.

S. Ashley, F. Saran, M. Brada, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters

S. Ashley, M. Brada, H. Forbes, 2022 .

Endometrial cancer during tamoxifen treatment.

T. Powles, S. Ashley, 1994, Lancet.

Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysis

S. Ashley, B. Gusterson, S. Ashley, 1990, The Journal of pathology.

Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.

S. Ashley, M. Brada, G. Minniti, 2005, The Journal of clinical endocrinology and metabolism.

Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital.

T. Powles, S. Ashley, C. Harmer, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

J. Bliss, S. Ashley, D. Ford, 1992, BMJ.

Postoperative radiotherapy in the management of spinal cord ependymoma.

H. Bloom, B. Bell, S. Ashley, 1991, Journal of neurosurgery.

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study

T. Powles, M. Dowsett, A. Makris, 2004, Breast Cancer Research and Treatment.

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.

C. Osborne, T. Powles, M. Dowsett, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The incidence of cerebrovascular accidents in patients with pituitary adenoma.

S. Ashley, M. Brada, S. Ashley, 1999, International journal of radiation oncology, biology, physics.

Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas

S. Ashley, S. Ashley, M. Brada, 2006, Clinical endocrinology.

Cytological evaluation of biological prognostic markers from primary breast carcinomas

C. Osborne, T. Powles, M. Dowsett, 1997, Breast Cancer Research and Treatment.

Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.

M. Dowsett, S. Ebbs, J. Salter, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma

T. Powles, M. Dowsett, S. Ashley, 2000, Cancer.

Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma.

A. Horwich, S. Ashley, M. Brada, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy.

H. Bloom, L. Vanuytsel, S. Ashley, 1992, International journal of radiation oncology, biology, physics.

Ploidy and proliferative index in medulloblastoma: useful prognostic factors?

R. Eeles, D. Tait, S. Ashley, 1993, European journal of cancer.

Craniopharyngioma: improving outcome by early recognition and treatment of acute complications.

D. Thomas, S. Ashley, J. Britton, 1997, International journal of radiation oncology, biology, physics.

Craniopharyngioma--a long-term results following limited surgery and radiotherapy.

H. Bloom, A. Horwich, S. Ashley, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

T. Powles, M. Dowsett, A. Makris, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET

S. Ashley, B. Baumert, F. Saran, 2008, Pediatric blood & cancer.

Improving outcomes in non-small cell lung cancer; optimum dose fractionation in radical radiotherapy matters.

S. Ashley, M. Brada, H. Forbes, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

T. Powles, T. Hickish, A. Makris, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma

C. Fisher, I. Judson, B. Seddon, 2008, Cancer.

Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.

M. Reni, S. Ashley, F. Saran, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term efficacy of fractionated radiotherapy for benign meningiomas.

S. Ashley, M. Brada, F. Soldá, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

R. Laing, S. Ashley, A. Warrington, 1997, International journal of radiation oncology, biology, physics.

Haematological toxicity of cranio-spinal irradiation.

S. Ashley, M. Brada, B. Rajan, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.

S. Ashley, J. Britton, M. Brada, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).

S. Ashley, G. Abel, B. Evans, 1989, Cancer research.

Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival.

T. Powles, A. Makris, S. Ashley, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study

S. Ashley, M. Brada, F. McDonald, 2020, Frontiers in Oncology.

An analysis of possible prognostic features of long term and short term survivors of metastatic breast cancer.

T. Powles, R. Coombes, J. Gibb, 1986, European journal of cancer & clinical oncology.

A systematic review of hypofractionated small volume radiotherapy for early stage non-small cell lung cancer (NSCLC)

J. Bedford, M. Partridge, S. Ashley, 2010 .

Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.

J. Bedford, M. Partridge, S. Ashley, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiotherapy for the treatment of recurrent craniopharyngioma.

S. Ashley, M. Brada, B. Rajan, 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

Immunohistochemical Phenotype after 20-Year Follow-Up of the Royal Marsden Tamoxifen Breast Cancer Prevention Trial (RMTBCPT).

M. Dowsett, I. Smith, S. Ashley, 2009 .

Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.

T. Powles, R. Coombes, I. Judson, 1990, European journal of cancer.

Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.

Stefan A Reinsberg, N. deSouza, S. Ashley, 2007, AJR. American journal of roentgenology.

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.

S. Ashley, J. Britton, M. Brada, 1999, International journal of radiation oncology, biology, physics.

Comparison of setup accuracy and intrafraction motion using stereotactic frame versus 3-point thermoplastic mask-based immobilization for fractionated cranial image guided radiation therapy.

Kevin Burke, Michelle Long, Ulrike Schick, 2013, Practical radiation oncology.

Fractionated stereotactic radiotherapy in the treatment of vestibular schwannoma (acoustic neuroma): predicting the risk of hydrocephalus.

C. Micallef, S. Ashley, M. Brada, 2011, International journal of radiation oncology, biology, physics.

Mitomycin C used in combination withmitoxantrone and methotrexate as first-line cytotoxic treatmentof disseminated breast cancer.

T. Powles, S. Ashley, C. Gallagher, 1987 .

Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study.

S. Ashley, M. Brada, D. Traish, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Lymphatic relapse in women with early breast cancer: a difficult management problem.

J. Yarnold, S. Ebbs, L. Gothard, 1999, European journal of cancer.

Nonsurgical management of esophageal adenocarcinoma.

D. Tait, D. Cunningham, S. Ashley, 2011, Clinical colorectal cancer.

Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.

B. Bell, S. Ashley, M. Brada, 1995, British Journal of Cancer.

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer.

T. Powles, J. Kanis, E. McCloskey, 1998, Journal of the National Cancer Institute.

Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

T. Powles, M. Dowsett, Jenny C. Chang, 2004, Breast Cancer Research and Treatment.

Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.

T. Hickish, M. Nicolson, D. Talbot, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial.

C. Ryan, S. Ashley, M. O'Brien, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Cone beam CT verification for active breathing control (ABC)-gated radiotherapy for lung cancer

S. Ashley, M. Brada, F. McDonald, 2014, Acta oncologica.

Chemoprevention of breast cancer

T. Powles, M. Dowsett, J. Davey, 1989 .

Phase I Trial and Pharmacokinetics of Trimelamol (TV^A^A^-Trihydroxymethyl-A^A^A^-trimethylmelamine)1

I. Judson, L. Gumbrell, S. Ashley, 2006 .

Long-term follow-up of young children with brain tumors after irradiation.

L. Jannoun, D. Tait, S. Ashley, 1994, International journal of radiation oncology, biology, physics.

Predicting axillary lymph node metastases in patients with T1 infiltrating ductal carcinoma of the breast.

S. Ashley, A. Neal, S Ashley, 2001, Breast.

Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection

S. Kyriazi, N. deSouza, S. Ashley, 2007, Acta radiologica.

The modulating effects of flurbiprofen on adriamycin plus vincristine or vindesine in the treatment of advanced breast cancer

T. Powles, R. Coombes, J. Gibb, 2004, Cancer Chemotherapy and Pharmacology.